David B. Burr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
David B. Burr has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- J.A. Shutter
Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA
2 shared publications - Matthew R. Allen
Indiana University School of Medicine
2 shared publications - Uma Sankar
Indiana University School of Medicine
2 shared publications - X. Ding
Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA
2 shared publications - A. Huls
Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
1 shared publication A. Seetharam
Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA
1 shared publication
Latest Publications
- 27 February 2023
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 31 (7) , 908-918
CAMKK2 is upregulated in primary human osteoarthritis and its inhibition protects against chondrocyte apoptosis
- 27 February 2023
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 31 (7) , 908-918
CAMKK2 is upregulated in primary human osteoarthritis and its inhibition protects against chondrocyte apoptosis
- Open Access
- 27 November 2021
- Published by Elsevier in Bone Reports
- Vol. 15, 101150
Micropetrosis in hemodialysis patients
- 27 November 2021
- Published by Elsevier in Bone Reports
- Vol. 15, 101150
Open AccessMicropetrosis in hemodialysis patients
- 17 September 2021
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 30 (1) , 124-136
Systemic inhibition or global deletion of CaMKK2 protects against post-traumatic osteoarthritis
- 17 September 2021
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 30 (1) , 124-136
Systemic inhibition or global deletion of CaMKK2 protects against post-traumatic osteoarthritis
- Open Access
- 31 January 2015
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 30 (8) , 1441-1444
In Vivo UTE-MRI Reveals Positive Effects of Raloxifene on Skeletal-Bound Water in Skeletally Mature Beagle Dogs
Raloxifene positively affects mechanical properties of the bone matrix in part through modification of skeletal‐bound water. The goal of this study was to determine if raloxifene‐induced alterations in skeletal hydration could be measured in vivo using ultra‐short echotime magnetic resonance imaging (UTE‐MRI). Twelve skeletally mature female beagle dogs (n = 6/group) were treated for 6 months with oral doses of saline vehicle (VEH, 1 mL/kg/d) or raloxifene (RAL, 0.5 mg/kg/d). After 6 months of treatment, all animals underwent in vivo UTE‐MRI of the proximal tibial cortical bone. UTE‐MRI signal intensity versus echotime curves were analyzed by fitting a double exponential to determine the short and long relaxation times of water with the bone (dependent estimations of bound and free water, respectively). Raloxifene‐treated animals had significantly higher bound water (+14%; p = 0.05) and lower free water (–20%) compared with vehicle‐treated animals. These data provide the first evidence that drug‐induced changes in skeletal hydration can be noninvasively assessed using UTE‐MRI. © 2015 American Society for Bone and Mineral Research. © 2015 American Society for Bone and Mineral Research.
- 31 January 2015
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 30 (8) , 1441-1444
Open AccessIn Vivo UTE-MRI Reveals Positive Effects of Raloxifene on Skeletal-Bound Water in Skeletally Mature Beagle Dogs
Raloxifene positively affects mechanical properties of the bone matrix in part through modification of skeletal‐bound water. The goal of this study was to determine if raloxifene‐induced alterations in skeletal hydration could be measured in vivo using ultra‐short echotime magnetic resonance imaging (UTE‐MRI). Twelve skeletally mature female beagle dogs (n = 6/group) were treated for 6 months with oral doses of saline vehicle (VEH, 1 mL/kg/d) or raloxifene (RAL, 0.5 mg/kg/d). After 6 months of treatment, all animals underwent in vivo UTE‐MRI of the proximal tibial cortical bone. UTE‐MRI signal intensity versus echotime curves were analyzed by fitting a double exponential to determine the short and long relaxation times of water with the bone (dependent estimations of bound and free water, respectively). Raloxifene‐treated animals had significantly higher bound water (+14%; p = 0.05) and lower free water (–20%) compared with vehicle‐treated animals. These data provide the first evidence that drug‐induced changes in skeletal hydration can be noninvasively assessed using UTE‐MRI. © 2015 American Society for Bone and Mineral Research. © 2015 American Society for Bone and Mineral Research.